HomeTLOG • OTCMKTS
add
Tetralogic Pharmaceuticals Corp
Previous close
$0.00
Market cap
20.00 USD
Avg Volume
934.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2015info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 38.50M | 23.34% |
Net income | -49.72M | -38.28% |
Net profit margin | — | — |
Earnings per share | -1.82 | -21.33% |
EBITDA | -38.31M | -23.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2015info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.41M | -61.99% |
Total assets | 64.02M | -45.10% |
Total liabilities | 69.96M | -15.92% |
Total equity | -5.94M | — |
Shares outstanding | 24.32M | — |
Price to book | -0.00 | — |
Return on assets | -26.64% | — |
Return on capital | -56.29% | — |
Cash Flow
Net change in cash
| (USD) | 2015info | Y/Y change |
|---|---|---|
Net income | -49.72M | -38.28% |
Cash from operations | -34.89M | -7.80% |
Cash from investing | 35.45M | 165.67% |
Cash from financing | 1.79M | -95.96% |
Net change in cash | 2.23M | 105.30% |
Free cash flow | -23.50M | -17.33% |
About
Founded
2001
Headquarters
Website
Employees
30
